| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $189.9M | -24.8% |
| R&D Expense | $10.9M | -2.9% |
| SG&A Expense | $58.6M | -24.9% |
| Operating Income | -$23.5M | +40.9% |
| Pre-tax Income | -$33.3M | +43.3% |
| Income Tax | $662K | -58.7% |
| Net Income | -$10.1M | +88.6% |
| EPS (Basic) | -$0.27 | +56.5% |
| EPS (Diluted) | -$0.27 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.6M | +8.4% |
| Accounts Receivable | $48.9M | -35.3% |
| Current Assets | $100.9M | -24.0% |
| Total Assets | $221.4M | -46.2% |
| Current Liabilities | $96.8M | -57.5% |
| Long-term Debt | $0 | -100.0% |
| Total Liabilities | $114.5M | -61.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.7M | -238.8% |
| Capital Expenditures | $691K | -28.3% |
| Investing Cash Flow | $178.7M | +1313.4% |
| Financing Cash Flow | -$154.6M | — |
| Free Cash Flow | -$21.4M | -202.4% |
| +56.5% |
| Stockholders' Equity |
| $104.8M |
| -3.7% |